Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Lymphocytic colitis (LC) can be mistakenly diagnosed as irritable bowel syndrome (IBS). In a previous study on IBS, some patients showed extremely high colonic chromogranin A cell density. Further examination of these patients showed that they suffered from LC. AIMS: To investigate whether chromogranin A cell density is increased in LC patients and to examine the possibility of using this increase as a marker for the diagnosis of LC. METHODS: Fifty-seven patients diagnosed with LC and 54 controls were included in the study. Biopsies from the right and left colon were obtained from both patients and controls, which were immunostained using the Avidin-biotin-complex method for chromogranin A, and cell density was quantified. RESULTS: In both the right and left colon of patients with LC, the density of chromogranin A was significantly higher than in controls. This increase in chromogranin A cells occurs whether the number of these cells is expressed as number/mm(2) epithelium or as number/field. Chromogranin A cell density for the right and left colon expressed as number of cells/mm(2) epithelium or as cell number/field showed a high sensitivity and specificity as a diagnostic marker for LC. CONCLUSIONS: Chromogranin A is a common marker for endocrine cells, and the present finding suggests that colonic hormones are involved in the pathophysiology of LC. The chromogranin cell density seems to be a good diagnostic marker with high sensitivity and specificity in both the right and left colon, thus sigmoidoscopy can be used in the diagnosis of LC using with this marker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inflammation meets metabolic disease: Gut feeling mediated by GLP-1
Zietek, T., & Rath, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00154 · Cited by 131
“Intriguingly, in human lymphocytic colitis, a condition with unclear etiology and characterized by accumulation of lymphocytes in the colonic epithelium and lamina propria, both chromogranin A (CgA) and PYY-positive cell densities were reported to be increased (150, 151).”
BackgroundRecent developments in the pathophysiology of irritable bowel syndrome
El-Salhy, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7621 · Cited by 111
Self-citationDiagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
Plavšić, I., Hauser, G., Tkalčić, M., Pletikosić, S., & Salkić, N. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/490183 · Cited by 37
“Consequently, IBS becomes not only debilitating for the patient, but also a great social and economic burden [5].”
Background
Metadata
- Authors
- El-Salhy, M., Gundersen, D., Hatlebakk, J. G., & Hausken, T.
- Venue
- Digestive Diseases and Sciences
- Published
- 2012-06-15
- Volume
- 57
- Issue
- 12
- Pages
- 3154-3159
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2040429341
- Cited by
- 42
- References
- 0
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis. https://app.cochat.ai/papers/10.1007/s10620-012-2249-6
- The paper
- El-Salhy, M., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2012). Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-012-2249-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.